Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher (TMO)
NYSE:TMO
TMO Stock Chart & Stats
$542.83
$0.83(0.15%)
At close: 4:00 PM EST
$542.83
$0.83(0.15%)
Day’s Range― - ―
52-Week Range$385.46 - $643.99
Previous CloseN/A
Volume471.20K
Average Volume (3M)2.23M
Market Cap
$203.95B
Enterprise Value$233.48B
Total Cash (Recent Filing)$10.11B
Total Debt (Recent Filing)$39.38B
Price to Earnings (P/E)30.6
Beta0.68
Next Earnings
Apr 29, 2026EPS Estimate
5.27Next Dividend Ex-DateN/A
Dividend Yield0.3%
Share Statistics
EPS (TTM)6.57
Shares Outstanding375,708,070
10 Day Avg. Volume2,628,869
30 Day Avg. Volume2,232,160
Financial Highlights & Ratios
PEG Ratio4.51
Price to Book (P/B)4.08
Price to Sales (P/S)4.89
P/FCF Ratio34.62
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue5.24
Enterprise Value/Gross Profit13.28
Enterprise Value/Ebitda20.67
Forecast
1Y Price Target
$677.73Price Target Upside24.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
EPS Forecast (FY)24.58
Revenue Forecast (FY)$46.84B
Bulls Say, Bears Say
Bulls Say
Analytical Instruments Market ShareRebound in Analytical Instruments, driven by chromatography, mass spectrometry, and electron microscopy, creates an opportunity for accelerated share gains in pharma and biopharma markets into 2026.
Bioproduction GrowthRobust bioproduction growth and bookings that outpace revenues support potential upside to 2026 top-line as onshoring and expanded U.S. production capacity lift competitiveness.
CDMO Demand And Capacity ConstraintsConstrained global sterile fill-finish capacity is driving strong demand for CDMO services and supporting pricing power and order momentum for the integrated CDMO–CRO Accelerator offering.
Bears Say
Guidance Uncertainty From Leadership And External HeadwindsChange in the chief financial officer combined with unusual headwinds such as tariffs and currency effects elevates uncertainty around financial guidance and execution.
Margin PressureAdjusted operating and gross margins running slightly below model indicate continued margin pressure that could compress earnings if cost recovery lags revenue growth.
Near-term Guidance RiskBelow-expectation near-term growth guidance signals cautious end-market demand and increases the risk that revenue recovery proves slower than investors expect.
Thermo Fisher News
TMO FAQ
What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest stock price was $385.46 and its highest was $643.99 in the past 12 months.
What is Thermo Fisher’s market cap?
Thermo Fisher’s market cap is $203.95B.
When is Thermo Fisher’s upcoming earnings report date?
Thermo Fisher’s upcoming earnings report date is Apr 29, 2026 which is in 80 days.
How were Thermo Fisher’s earnings last quarter?
Thermo Fisher released its earnings results on Jan 29, 2026. The company reported $6.57 earnings per share for the quarter, beating the consensus estimate of $6.449 by $0.121.
Is Thermo Fisher overvalued?
According to Wall Street analysts Thermo Fisher’s price is currently Undervalued.
Does Thermo Fisher pay dividends?
Thermo Fisher pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 0.3%. See more information on Thermo Fisher dividends here
What is Thermo Fisher’s EPS estimate?
Thermo Fisher’s EPS estimate is 5.27.
How many shares outstanding does Thermo Fisher have?
Thermo Fisher has 375,708,070 shares outstanding.
What happened to Thermo Fisher’s price movement after its last earnings report?
Thermo Fisher reported an EPS of $6.57 in its last earnings report, beating expectations of $6.449. Following the earnings report the stock price went down -2.608%.
Which hedge fund is a major shareholder of Thermo Fisher?
Currently, no hedge funds are holding shares in TMO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Thermo Fisher Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$677.73 (24.85% Upside)
$677.73 (24.85% Upside)
Blogger Sentiment
Bullish
TMO Sentiment 72%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 920.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $57.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.88%
12-Months-Change
Fundamentals
Return on Equity
13.04%
Trailing 12-Months
Asset Growth
13.38%
Trailing 12-Months
Company Description
Thermo Fisher
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TMO Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a largely positive operational and financial picture: solid top-line growth, strong adjusted EPS growth, robust cash generation, aggressive strategic M&A and product innovation, and constructive 2026 guidance (3%–4% organic growth and 6%–8% EPS growth). Headwinds from tariffs, foreign exchange volatility, China and academic/government softness, margin pressure in Analytical Instruments, and elevated leverage represent notable near-term risks but appear manageable given the company’s PPI-driven productivity, capital deployment discipline, and pipeline of innovations and strategic deals.View all TMO earnings summariesTMO Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
TMO Stock 12 Month Forecast
Average Price Target
$677.73
▲(24.85% Upside)
Technical Analysis
Ownership Overview
0.13% Insiders
23.96% Mutual Funds
0.36% Other Institutional Investors
56.15% Public Companies and Individual Investors